tofacitinib
pfizer
['tofa']
maya buch on major adverse cv events in tofa vs tnfi. post-hoc analysis of phase 3b/4 data looking at cohort enriched for cv events. #acr22 #latebreaking
Rheumatology nerd. Opinions are my own (except when wrong)